Pavblu 2 mg (0.05 mL of 40 mg/mL solution) injection Images
Generic Name: aflibercept
This medication has been identified as Pavblu 2 mg (0.05 mL of 40 mg/mL solution) injection. It is supplied by Amgen Inc.
Pavblu is used in the treatment of Macular Degeneration; Macular Edema Following Retinal Vein Occlusion; Diabetic Retinopathy; Macular Edema; Diabetic Macular Edema and belongs to the drug class anti-angiogenic ophthalmic agents. Risk cannot be ruled out during pregnancy. Pavblu 2 mg (0.05 mL of 40 mg/mL solution) injection is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Pavblu
- Generic Name
- aflibercept
- Strength
- 2 mg (0.05 mL of 40 mg/mL solution) injection
- Availability
- Prescription only
- Drug Class
- Anti-angiogenic ophthalmic agents
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Amgen Inc.
- National Drug Code (NDC)
- multiple
See also:
More about Pavblu (aflibercept ophthalmic)
- Check interactions
- Compare alternatives
- Reviews (1)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: anti-angiogenic ophthalmic agents
- Breastfeeding
Patient resources
Other brands
Eylea, Eylea HD, Yesafili, Ahzantive, ... +2 more
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.